首页> 外文会议>Proceedings of the 29th Annual Meeting of the Controlled Release Society >PEGylation of water soluble anticancer drug, Ara-C: Syntheses and in vitro in vivo Anti-Tumor Efficacy
【24h】

PEGylation of water soluble anticancer drug, Ara-C: Syntheses and in vitro in vivo Anti-Tumor Efficacy

机译:水溶性抗癌药物Ara-C的PEG化:合成及体内外抗肿瘤功效

获取原文

摘要

We designed a systematic study of N~4 PEG-prodrugs of ara-C and synthesized a series of di-, tetra-, and octa-substituted derivatives. The greater loading of the PEG backbone appears to have achieved a minimum threshold concentration for the therapeutic delivery of ara-C and showed better efficacy in both ascites and solid tumor models.
机译:我们设计了ara-C的N〜4种PEG前药的系统研究,并合成了一系列二,四和八取代的衍生物。 PEG主链的较大负载似乎已达到ara-C治疗性递送的最低阈值浓度,并且在腹水和实体瘤模型中均显示出更好的功效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号